Bayesian Capital Management’s Agilon Health AGL Stock Holding History

Bayesian Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,030	Closed	-$901K	–	715
2023 Q3	$901K	Sell	2,030 -908	-31%	-$410K	0.1%	248
2023 Q2	$1.27M	Buy	2,938 +1,980	+207%	+$1.11M	0.14%	201
2023 Q1	$569K	Buy	+958	New	+$537K	0.07%	355
2022 Q4	–	Sell	-721	Closed	-$422K	–	752
2022 Q3	$422K	Buy	721 +85	+13%	+$50.9K	0.09%	324
2022 Q2	$347K	Sell	636 -384	-38%	-$194K	0.06%	431
2022 Q1	$646K	Buy	+1,020	New	+$526K	0.1%	309

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bayesian Capital Management's AGL Position: Q4 2023 in Review

Bayesian Capital Management sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 2,030 shares — an estimated $901K sold.

Bayesian Capital Management first reported a position in AGL in Q1 2022 and held it in 6 quarters. The position peaked at $1.27M in Q2 2023. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

Bayesian Capital Management reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
Bayesian Capital Management sold 2,030 Agilon Health shares in Q4 2023, an estimated $901K.
Bayesian Capital Management first reported a position in Agilon Health in Q1 2022 and held it in 6 quarters.
Bayesian Capital Management's Agilon Health position peaked at $1.27M in Q2 2023.
193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.